Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
Diana Gaete, Diego A. Rodríguez, Deepika Watts, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 988-988
Open Access | Times Cited: 25

Showing 25 citing articles:

Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions
И. Ф. Беленичев, Olena Popazova, Nina Bukhtiyarova, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 108-108
Open Access | Times Cited: 2
Hypoxia Pathway Proteins and Their Impact on the Blood Vasculature
Diego A. Rodríguez, Deepika Watts, Diana Gaete, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9191-9191
Open Access | Times Cited: 46
Vascularized Tumor Spheroid-on-a-Chip Model Verifies Synergistic Vasoprotective and Chemotherapeutic Effects
Zhiwei Hu, Yuanxiong Cao, Edgar A. Galan, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 3, pp. 1215-1225
Closed Access | Times Cited: 38
Catalase application in cancer therapy: Simultaneous focusing on hypoxia attenuation and macrophage reprogramming
Alireza Najafi, Maryam Keykhaee, Hossein Khorramdelazad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113483-113483
Open Access | Times Cited: 30
Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF/VEGFR pathway
Patryk Lorenc, Agata Sikorska, Sara Molenda, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117585-117585
Closed Access | Times Cited: 8
Glutamine Metabolism and Prostate Cancer
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Hypoxia signaling: Challenges and opportunities for cancer therapy
Mircea Ivan, Melissa L. Fishel, Oana Tudoran, et al.
Seminars in Cancer Biology (2021) Vol. 85, pp. 185-195
Open Access | Times Cited: 31
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications
Sungmi Jeon, Miyeon Jeon, Sanga Choi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4430-4430
Open Access | Times Cited: 13
Hypoxia-Inducible Factor 1-Alpha (HIF-1α) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting
Mohd Basheeruddin, Sana Qausain
Cureus (2024)
Open Access | Times Cited: 4
Over a decade of successful treatment with tocilizumab in a maintenance hemodialysis patient for Castleman disease: a case report and literature review
Aya Shima, Takahiro Shima, C. Matsuo, et al.
Renal Replacement Therapy (2025) Vol. 11, Iss. 1
Open Access
Navigating the tumor landscape: VEGF, MicroRNAs, and the future of cancer treatment
K P Ameya, Parveen Usman, Durairaj Sekar
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2025) Vol. 1868, Iss. 2, pp. 195091-195091
Closed Access
Hypoxia signaling pathway: A central mediator in endocrine tumors
Deepika Watts, Mangesh T. Jaykar, Nicole Bechmann, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 8
Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review
Jie Zhang
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 11, pp. 2921-2953
Closed Access | Times Cited: 3
From Vessels to Neurons—The Role of Hypoxia Pathway Proteins in Embryonic Neurogenesis
Barbara K. Stepien, Ben Wielockx
Cells (2024) Vol. 13, Iss. 7, pp. 621-621
Open Access | Times Cited: 3
Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma
Lassi Luomala, Kalle Mattila, Paula Vainio, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Enhanced CRC Growth in Iron-Rich Environment, Facts and Speculations
Marcello Chieppa, Marianna Kashyrina, Alessandro Miraglia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12389-12389
Open Access | Times Cited: 2
Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis
Chin‐Lin Guo
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Structural Characterization of Hypoxia Inducible Factor α—Prolyl Hydroxylase Domain 2 Interaction through MD Simulations
Giorgia F Camagni, Giovanni Minervini, Silvio C. E. Tosatto
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4710-4710
Open Access | Times Cited: 4
Upconversion-Nanoparticle-Based Smart Drug-Delivery Platforms for Multimodal Imaging-Guided Cancer Therapies
Jiahui Yan, Kai Shao, Lijuan Wu, et al.
ACS Applied Nano Materials (2022) Vol. 5, Iss. 10, pp. 15473-15487
Closed Access | Times Cited: 7
PHD1-3 oxygen sensors in vivo—lessons learned from gene deletions
Agnieszka E. Jucht, Carsten C. Scholz
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 9, pp. 1307-1337
Open Access | Times Cited: 1
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway
Lisha Xiang, Hao Wei, Wentao Ye, et al.
International Journal of Oncology (2023) Vol. 64, Iss. 1
Open Access | Times Cited: 2
Outcomes and complications of hemodialysis in patients with renal cancer following bilateral nephrectomy
Bing Shen, Feng Luo, Nan Yuan, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
Novel Compounds as PHD Inhibitors for Treating Heart, Lung, Liver, and Kidney Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 12, pp. 1868-1869
Open Access | Times Cited: 3
Role of mechanotransduction in stem cells and cancer progression
Amit Kumar Dey, Subhamay Adhikary, Pournami Gopan, et al.
Elsevier eBooks (2023), pp. 51-76
Closed Access
Sphingolipids as Oxygen Sensors and Major Orchestrators of Cellular Responses to Hypoxia
Marguerite Mrad, Tarek Bou Dargham, Mohamad B. Moumneh, et al.
Springer eBooks (2022), pp. 1-19
Closed Access
Page 1

Scroll to top